Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | GRK6 | P43250 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | FBP1 | P09467 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.35 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10347629 | 0.98 | CYP2A6 (0.51) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 | |
| SCHEMBL11926858 | 0.86 | CYP2A6 (0.62) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 | |
| SCHEMBL3062248 | 0.78 | CYP2A6 (0.53) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 | |
| SCHEMBL1077009 | 0.78 | CYP2A6 (0.53) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 | |
| SCHEMBL3147154 | 0.78 | CYP2A6 (0.53) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 | |
| SCHEMBL30797819 | 0.78 | CYP2A6 (0.53) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 | |
| SCHEMBL1187043 | 0.78 | CYP2A6 (0.53) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 | |
| SCHEMBL6271346 | 0.78 | CYP2A6 (0.53) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 | |
| SCHEMBL1788007 | 0.78 | CYP2A6 (0.53) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 | |
| SCHEMBL9454459 | 0.78 | CYP2A6 (0.53) | CYP2A6KDM4EALDH1A1SMN1; SMN2CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2226317-B1 | ARYL (1H-1,2,4-TRIAZOL-1-YL) COMPOUND, AND PROCESS FOR PRODUCTION THEREOF | IHARA CHEMICAL IND CO (JP) | 2015-08-12 | — | — | EP | claimed |
| US-20130023666-A1 | ARYL (1H-1,2,4-TRIAZOL-1-YL) COMPOUND, AND PROCESS FOR PRODUCTION THEREOF | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2013-01-24 | — | — | US | claimed |
| US-20100256386-A1 | ARYL (1H-1,2,4-TRIAZOL-1-YL) COMPOUND AND PROCESS FOR PRODUCTION THEREOF | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-10-07 | — | — | US | claimed |
| EP-2226317-A1 | ARYL (1H-1,2,4-TRIAZOL-1-YL) COMPOUND, AND PROCESS FOR PRODUCTION THEREOF | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-09-08 | — | — | EP | claimed |
| WO-2020065613-A1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-04-02 | — | — | WO | disclosed |
| EP-2632255-B1 | DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES | MERCK SHARP & DOHME (US) | 2017-06-21 | — | — | EP | disclosed |
| CN-103664811-B | (1H-1,2,4-triazol-1-yl) aryl compound and preparation method thereof | IHARA CHEMICAL IND CO. (JP) | 2015-09-16 | — | — | CN | disclosed |
| EP-2226317-B1 | ARYL (1H-1,2,4-TRIAZOL-1-YL) COMPOUND, AND PROCESS FOR PRODUCTION THEREOF | IHARA CHEMICAL IND CO (JP) | 2015-08-12 | — | — | EP | disclosed |
| CN-101878197-B | Method for producing 3-mercaptoaniline compound | IHARA CHEMICAL IND CO | 2015-01-07 | — | — | CN | disclosed |
| CN-103664811-A | Aryl (1h-1,2,4-triazol-1-yl) compound, and process for production thereof | IHARA CHEMICAL IND CO | 2014-03-26 | — | — | CN | disclosed |
| CN-103664811-A | Aryl (1h-1,2,4-triazol-1-yl) compound, and process for production thereof | IHARA CHEMICAL IND CO | 2014-03-26 | — | — | CN | disclosed |
| US-8648207-B2 | Aryl (1H-1,2,4-triazol-1-yl) compound, and process for production thereof | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 2014-02-11 | — | — | US | disclosed |
| EP-2047333-A1 | NEGATIVE-WORKING RADIATION-SENSITIVE COMPOSITIONS AND IMAGEABLE MATERIALS | EASTMAN KODAK COMPANY (US) | 2009-04-15 | — | — | EP | disclosed |
| WO-2009023112-A1 | NEGATIVE-WORKING IMAGEABLE ELEMENTS AND METHODS OF USE | EASTMAN KODAK COMPANY (US) | 2009-02-19 | — | — | WO | disclosed |
| WO-2008156552-A1 | ON-PRESS DEVELOPABLE NEGATIVE-WORKING IMAGEABLE ELEMENTS AND METHODS OF USE | EASTMAN KODAK COMPANY (US) | 2008-12-24 | — | — | WO | disclosed |
| WO-2008150441-A1 | IMAGEABLE ELEMENTS AND METHODS OF USE IN NEGATIVE WORKING LITHOGRAPHIC PRINTING PLATES | EASTMAN KODAK COMPANY (US) | 2008-12-11 | — | — | WO | disclosed |
| WO-2008127549-A1 | NEGATIVE-WORKING IMAGEABLE ELEMENTS AND METHODS OF USE | EASTMAN KODAK COMPANY (US) | 2008-10-23 | — | — | WO | disclosed |
| WO-2008036170-A1 | NEGATIVE-WORKING RADIATION-SENSITIVE COMPOSITIONS AND IMAGEABLE MATERIALS | EASTMAN KODAK COMPANY (US) | 2008-03-27 | — | — | WO | disclosed |
| WO-2008027227-A1 | METHOD OF IMAGING AND DEVELOPING NEGATIVE-WORKING ELEMENTS | EASTMAN KODAK COMPANY (US) | 2008-03-06 | — | — | WO | disclosed |
| WO-2008013766-A1 | NEGATIVE-WORKING RADIATION-SENSITIVE COMPOSITIONS AND IMAGEABLE MATERIALS | EASTMAN KODAK COMPANY (US) | 2008-01-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256386-A1 | ARYL (1H-1,2,4-TRIAZOL-1-YL) COMPOUND AND PROCESS FOR PRODUCTION THEREOF | CYP1A1, CYP2S1, NAT1 | CYP2A6 28/4885KDM4E 2741/4885ALDH1A1 217/4885 |
| US-20130023666-A1 | ARYL (1H-1,2,4-TRIAZOL-1-YL) COMPOUND, AND PROCESS FOR PRODUCTION THEREOF | CYP1B1, CYP1A1, AOC3 | CYP2A6 19/4885KDM4E 3697/4885ALDH1A1 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.